Recent advances in managing axial spondyloarthritis [version 1; peer review: 2 approved]
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that predominantly affects the axial skeleton. The advent of biologic drugs has transformed the management of patients with axSpA. However, non-steroidal anti-inflammatory drugs remain the first-line drug treatment for axSpA...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2020-07-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/9-697/v1 |